ArticleInternational journal of radiation oncology, biology, physics2020
Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.
Article in International journal of radiation oncology, biology, physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- When Is Telemedicine Appropriate in the Management of Head and Neck Cancer? A Mixed-Methods Assessment Among Patients and Physicians.JCO oncology practice · 2024Article
- Patient Safety and Satisfaction With Fully Remote Management of Radiation Oncology Care.JAMA network open · 2024Article
- Implementation of a Novel Chart Rounds Application to Facilitate Peer Review in a Virtual Academic Environment.Advances in radiation oncology · 2024Article
- Telemedicine in cancer care during COVID-19 pandemic: a systematic mapping study.Health and technology · 2023Article
- The impact and implications of virtual supportive cancer care during the COVID-19 pandemic: integrating patient and clinician perspectives.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Exploring cancer patients', caregivers', and clinicians' utilisation and experiences of telehealth services during COVID-19: A qualitative study.Patient education and counseling · 2022Article
- Telemedicine for Retinal Disease During the COVID-19 Pandemic: Survey of the Patient Perspective.Ophthalmology and therapy · 2022Article
- Access to Radiation Therapy: From Local to Global and Equality to Equity.JCO global oncology · 2022Review
- Oncology patients' communication experiences during COVID-19: comparing telehealth consultations to in-person visits.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care.Cancer medicine · 2022Article
- Article
- The Utilization and Benefits of Telehealth Services by Health Care Professionals Managing Breast Cancer Patients during the COVID-19 Pandemic.Healthcare (Basel, Switzerland) · 2021Review
- The New Normal? Patient Satisfaction and Usability of Telemedicine in Breast Cancer Care.Annals of surgical oncology · 2021Article
- Radiation oncology practice during COVID-19 pandemic in developing countries.World journal of clinical cases · 2021Article
- The Research on Patient Satisfaction with Remote Healthcare Prior to and during the COVID-19 Pandemic.International journal of environmental research and public health · 2021Review
- Telemedicine Use and Satisfaction Among Radiation Oncologists During the COVID-19 Pandemic: Evaluation of Current Trends and Future Opportunities.Advances in radiation oncologyArticle
- Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19.Advances in radiation oncologyArticle
- Physician Perspectives on Telemedicine in Radiation Oncology.Advances in radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTelemedicine was rapidly and ubiquitously adopted during the COVID-19 pandemic. However, there are growing discussions as to its role postpandemic. METHODS AND MATERIALS: We surveyed patients, radiation oncology (RO) attendings, and RO residents to assess their experience with telemedicine. Surveys addressed quality of patient care and utility of telemedicine for teaching and learning core competencies. Satisfaction was rated on a 6-point Likert-type scale. The quality of teaching and learning was graded on a 5-point Likert-type scale, with overall scores calculated by the average rating of each core competency required by the Accreditation Council for Graduate Medical Education (range, 1-5).
resultsResponses were collected from 56 patients, 12 RO attendings, and 13 RO residents. Patient feedback was collected at 17 new-patient, 22 on-treatment, and 17 follow-up video visits. Overall, 88% of patients were satisfied with virtual visits. A lower proportion of on-treatment patients rated their virtual visit as "very satisfactory" (68.2% vs 76.5% for new patients and 82.4% for follow-ups). Only 5.9% of the new patients and none of the follow-up patients were dissatisfied, and 27% of on-treatment patients were dissatisfied. The large majority of patients (88%) indicated that they would continue to use virtual visits as long as a physical examination was not needed. Overall scores for medical training were 4.1 out of 5 (range, 2.8-5.0) by RO residents and 3.2 (range, 2.0-4.0) by RO attendings. All residents and 92% of attendings indicated they would use telemedicine again; however, most indicated that telemedicine is best for follow-up visits.
conclusionsTelemedicine is a convenient means of delivering care to patients, with some limitations demonstrated for on-treatment patients. The majority of both patients and providers are interested in using telemedicine again, and it will likely continue to supplement patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.